Apr
25
2025
Bristol Myers’ Cobenfy fails to meet main goal as add-on treatment for schizophrenia
(Reuters) -Bristol Myers Squibb said on Tuesday its drug Cobenfy failed to show a statistically significant difference in a late-stage trial studying it as an add-on treatment for schizophrenia, …